Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedJan 17, 2018Anastrozole 0.5 mg CapsulesLabeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.KRS Global Biotechnology, Inc · D-0161-2018Class IITerminatedJan 17, 2018Sterile EyewashLack of sterility assurance: leaking containers which could lead to exposure to infectious agents.Medex Cardio-Pulmonary Inc., d.b.a. Smiths Medical Company · D-0160-2018Class IITerminatedJan 17, 2018Sterile EyewashLack of sterility assurance: leaking containers which could lead to exposure to infectious agents.Medex Cardio-Pulmonary Inc., d.b.a. Smiths Medical Company · D-0159-2018Class IITerminatedJan 17, 2018Sterile EyewashLack of sterility assurance: leaking containers which could lead to exposure to infectious agents.Medex Cardio-Pulmonary Inc., d.b.a. Smiths Medical Company · D-0158-2018Class IITerminatedJan 17, 2018Sterile EyewashLack of sterility assurance: leaking containers which could lead to exposure to infectious agents.Medex Cardio-Pulmonary Inc., d.b.a. Smiths Medical Company · D-0157-2018Class IITerminatedJan 17, 2018Ephedrine sulfate 5 mg/mL in 0.9% Sodium Chloride 10 mL in Single Dose SyringeLabeling: Incorrect or Missing Lot and/or Exp Date - product label was missing lot number and beyond use date.SCA Pharmaceuticals · D-0156-2018Class IITerminatedJan 17, 2018Gabapentin TabletsLabeling: Label Mix-Up.some bottles labeled as Gabapentin 800 mg contain Gabapentin 600 mgSolco Healtcare US LLC · D-0155-2018Class IITerminatedJan 17, 2018ViokaceSubpotent Drug: One lot of Viokace is being recalled since product stability testing results did not meet the specifications for enzyme profile.Allergan · D-0154-2018Class IIITerminatedJan 17, 2018Enoxaparin SodiumLabeling: Label Error on Declared Strength. A single syringe labeled as 150 mg/1.0 mL was found packaged in a blister labeled as 120 mg/mLSanofi-Aventis U.S. LLC · D-0153-2018Class ITerminatedJan 10, 2018Midazolam InjectionLabeling: Label MIX-UP. Blister Packages, Labeled as Midazolam injection, USP, 2 mg / 2 ml, Containing Syringes of Ondansetron Injection, USP, 4 mg / 2 mLFresenius Kabi USA, LLC · D-0152-2018Class IITerminatedJan 10, 2018Zoloft (sertraline HCl) tablets 25 mg*SUPERPOTENT: Weight variations resulting in tablets that are sub and super potentPfizer Inc. · D-0151-2018Class ITerminatedJan 10, 2018diphenoxylate hydrochloride and atropine sulfate tabletsSUPERPOTENT: Weight variations resulting in tablets that are sub and super potentPfizer Inc. · D-0150-2018Class ITerminatedJan 10, 2018Enhanced Vegetal Vigra 200 mg CapsulesMarketed without an Approved NDA/ANDA; FDA analysis found product to be tainted with Sildenafil.Natures Supplement · D-0149-2018Class IITerminatedJan 3, 2018Succinylcholine chloride 100 mg in 5 mL syringeLack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified...SSM Health Care St. Louis DBA SSM St. Clare Health Center · D-0145-2018Class IITerminatedJan 3, 2018Phenylephrine 1000 mcg in 0.9% Sodium Chloride 10 mLLack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified...SSM Health Care St. Louis DBA SSM St. Clare Health Center · D-0144-2018Class IITerminatedJan 3, 2018Oxytocin 30 units in 0.9% Sodium Chloride 500 mLLack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified...SSM Health Care St. Louis DBA SSM St. Clare Health Center · D-0143-2018Class IITerminatedJan 3, 2018Norepinephrine 8 mg in dextrose 5% 250 mLLack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified...SSM Health Care St. Louis DBA SSM St. Clare Health Center · D-0142-2018Class IITerminatedJan 3, 2018Neostigmine Methylsulfate 5 mg/5 mLLack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified...SSM Health Care St. Louis DBA SSM St. Clare Health Center · D-0141-2018Class IITerminatedJan 3, 2018Morphine 50 mg in 0.9% Sodium Chloride 5 mL PCALack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified...SSM Health Care St. Louis DBA SSM St. Clare Health Center · D-0140-2018Class IITerminatedJan 3, 2018HYDROmorphone 10 mg in 0.9% Sodium Chloride 50 mL PCALack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified...SSM Health Care St. Louis DBA SSM St. Clare Health Center · D-0139-2018Class IITerminatedJan 3, 2018Fentanyl 2 mcg/mL and ropivacaine 0.2% in 0.9% Sodium Chloride 150 mLLack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified...SSM Health Care St. Louis DBA SSM St. Clare Health Center · D-0138-2018Class IITerminatedJan 3, 2018Amiodarone 900 mg in dextrose 5% 500 mLLack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified...SSM Health Care St. Louis DBA SSM St. Clare Health Center · D-0137-2018Class IITerminatedJan 3, 2018Fentanyl 10 mcg in 0.9% Sodium Chloride 1 mLLack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified...SSM Health Care St. Louis DBA SSM St. Clare Health Center · D-0136-2018Class IIITerminatedJan 3, 2018Bayer Chewable Low Dose Aspirin 81 mg Orange Flavored 36 tabletsFailed Stability SpecificationsBayer HealthCare Pharmaceuticals, Inc. · D-0135-2018Class IITerminatedJan 3, 2018Alcohol Prep PadsLack of Assurance of Sterility and cGMP DeviationsSimple Diagnostics, Inc. · D-0134-2018Class IIITerminatedJan 3, 2018AuryxiaPresence of Foreign Substance: Reports have been received of damaged StripPax packets containing silica gel desiccant potentially allowing the silica gel granules to...Keryx Biopharmaceuticals, Inc. · D-0133-2018Class IIITerminatedJan 3, 2018HYDROmorphone HCl in 0.9% Sodium Chloride InjectionLabeling: Incorrect or Missing Lot and/or Exp. DatePharmedium Services, LLC · D-0132-2018Class IIITerminatedJan 3, 2018morphine Sulfate in 0.9% Sodium Chloride Injection 1 mL Total Volume 2 mg per mLLabeling: Incorrect or Missing Lot and/or Exp. DatePharmedium Services, LLC · D-0131-2018Class IIITerminatedJan 3, 2018morphine Sulfate in 0.9% Sodium Chloride Injection 2 mL Total Volume 1 mg per mLLabeling: Incorrect or Missing Lot and/or Exp. DatePharmedium Services, LLC · D-0130-2018Class IITerminatedDec 27, 2017All Sterile Products within expiryLack of Assurance of Sterility .Vital Rx, Inc. dba Atlantic Pharmacy and Compounding · D-0148-2018Class IITerminatedDec 27, 2017Neostigmine MethylsulfateStability Date Doesn't Support Expiry: labeling error indicating a beyond use date that exceeds current stability data.Premier Pharmacy Labs Inc · D-0129-2018Class IITerminatedDec 27, 2017Maximum Strength Zephrex-DMicrobial Contamination of Non-Sterile ProductsL. Perrigo Company · D-0128-2018Class IIITerminatedDec 27, 2017Ciprofloxacin in DextroseSuperpotentClaris Lifesciences Inc · D-0127-2018Class ITerminatedDec 27, 2017NATURAL HERBAL COFFEE AMPTMarketed Without An Approved NDA/ANDA: FDA analysis found the product to contain undeclared sildenafil and tadalafil and undeclared milk. The presence of sildenafil and...The Ampt Life, LLC · D-0126-2018Class IITerminatedDec 27, 2017AmethystLabeling: Incorrect Instructions. "TABLETS IN WEEK 4 ARE INACTIVE" printed on the blister foil and package insert, however,all tablets are active.Teva Pharmaceuticals USA · D-0125-2018Class IIITerminatedDec 27, 2017Fluconazole InjectionSuperpotentRenaissance Lakewood, LLC · D-0124-2018Class ITerminatedDec 27, 2017Vancomycin Hydrochloride for InjectionPresence of Particulate Matter: glass particulate found in vialPfizer Inc. · D-0123-2018Class ITerminatedDec 27, 2017LaBri's Body Health XPLODE 30 capsules Exclusively distribute worldwide by LaBri's Body HealthMarketed Without An Approved NDA/ANDA: Tainted Product Marketed As a Dietary Supplements: products found to be tainted with sibutramine making these unapproved drugs.EZWeightLossTX LLC · D-0122-2018Class ITerminatedDec 27, 2017LaBri's Body Health Atomic 60 Capsules ExclusivelyMarketed Without An Approved NDA/ANDA: Tainted Product Marketed As a Dietary Supplements: products found to be tainted with sibutramine making these unapproved drugs.EZWeightLossTX LLC · D-0121-2018Class ITerminatedDec 27, 2017Lorazepam Oral ConcentrateDefective Delivery System: the dropper measurement markings may be reversed, shifted or missing.Amneal Pharmaceuticals of New York, LLC · D-0120-2018